UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Immunomodulatory Effects of Diet and Nutrients in Systemic Lupus Erythematosus (SLE): A Systematic Review

Frontiers in immunology, 2020-07, Vol.11, p.1477-1477

2020

Volltextzugriff (PDF)

Thromboembolic Adverse Drug Reactions in Janus Kinase (JAK) Inhibitors: Does the Inhibitor Specificity Play a Role?

International journal of molecular sciences, 2021-02, Vol.22 (5), p.2449

2021

Volltextzugriff (PDF)

MicroRNA (miRNA): A New Dimension in the Pathogenesis of Antiphospholipid Syndrome (APS)

International journal of molecular sciences, 2020-03, Vol.21 (6), p.2076

2020

Volltextzugriff (PDF)

Differential Impact of Biologic Therapy on Heart Function Biomarkers in Rheumatoid Arthritis Patients: Observational Study on Etanercept, Adalimumab, and Tocilizumab

Current pharmaceutical design, 2022-01, Vol.28 (24), p.2029-2037

2022

Volltextzugriff (PDF)

Hyperferritinaemia: An Iron Sword of Autoimmunity

Current pharmaceutical design, 2019-01, Vol.25 (27), p.2909-2918

2019

Volltextzugriff (PDF)

Editorial: Autoimmunity and cardiovascular diseases

Frontiers in cardiovascular medicine, 2023-07, Vol.10, p.1249525-1249525

2023

Volltextzugriff (PDF)

Vitamin D Status in Patients with Primary Antiphospholipid Syndrome (PAPS): A Systematic Review and Meta-Analysis

Antibodies (Basel), 2024-03, Vol.13 (1), p.22

2024

Volltextzugriff (PDF)

Clinical Aspects of Janus Kinase (JAK) Inhibitors in the Cardiovascular System in Patients with Rheumatoid Arthritis

International journal of molecular sciences, 2020-10, Vol.21 (19), p.7390

2020

Volltextzugriff (PDF)

Cytometric Characterization of Main Immunocompetent Cells in Patients with Systemic Sclerosis: Relationship with Disease Activity and Type of Immunosuppressive Treatment

Journal of clinical medicine, 2019-05, Vol.8 (5), p.625

2019

Volltextzugriff (PDF)

Bimodal Function of Anti-TNF Treatment: Shall We Be Concerned about Anti-TNF Treatment in Patients with Rheumatoid Arthritis and Heart Failure?

International journal of molecular sciences, 2018-06, Vol.19 (6), p.1739

Kotyla, Przemyslaw J

2018

Volltextzugriff (PDF)

Prevalence of antiphospholipid antibodies in Behçet's disease: A systematic review and meta-analysis

PloS one, 2020-01, Vol.15 (1), p.e0227836-e0227836

2020

Volltextzugriff (PDF)

Short course of simvastatin has no effect on markers of endothelial activation in normolipidemic patients with systemic sclerosis

Journal of international medical research, 2018-05, Vol.46 (5), p.1893-1901

Kotyla, Przemyslaw J.

2018

Volltextzugriff (PDF)

Are Janus Kinase Inhibitors Superior over Classic Biologic Agents in RA Patients?

BioMed research international, 2018-01, Vol.2018 (2018), p.1-9

2018

Volltextzugriff (PDF)

Statins Therapy for Connective Tissue Diseases: New Therapeutic Opportunities

Endocrine, metabolic & immune disorders drug targets, 2018-03, Vol.18 (2), p.135-147

2018

Volltextzugriff (PDF)

Insulin resistance varies across connective tissue diseases patients: comparison between rheumatoid arthritis, systemic lupus erythematosus and systemic sclerosis

Clinical and experimental rheumatology, 2019-11, Vol.37 Suppl 122 (6), p.14

Kotyla, Przemyslaw J

2019

Volltextzugriff (PDF)

Low dose of simvastatin reduces disease activity and improves endothelial function in patients with systemic lupus erythematosus

Clinical and experimental rheumatology, 2019-11, Vol.37 Suppl 122 (6), p.6

Kotyla, Przemyslaw J

2019

Volltextzugriff (PDF)

Serum concentration of surfactant protein D in patients with systemic sclerosis: The potential marker of the interstitial lung disease severity

Best practice & research. Clinical rheumatology, 2018-08, Vol.32 (4), p.541-549

2018

Volltextzugriff (PDF)

Infliximab treatment increases left ventricular ejection fraction in patients with rheumatoid arthritis: assessment of heart function by echocardiography, endothelin 1, interleukin 6, and NT-pro brain natriuretic peptide

Journal of rheumatology, 2012-04, Vol.39 (4), p.701-706

2012

Volltextzugriff (PDF)

Atorvastatin Pleiotropic Effects Mediated Via Suppression of TNF-α in Congestive Heart Failure Patients with Initial Normal TNF-α Levels

The Journal of heart and lung transplantation, 2009, Vol.28 (1), p.114-115

Kotyla, Przemyslaw J., MD

2009

Volltextzugriff (PDF)

Fibroblast Growth Factor 23 to Alpha-Klotho Index Correlates with Systemic Sclerosis Activity: A Proposal for Novel Disease Activity Marker

Journal of clinical medicine, 2018-12, Vol.7 (12), p.558

2018

Volltextzugriff (PDF)

Patogeneza zapaleń naczyń związanych z przeciwciałami przeciwko cytoplazmie neutrofilów

Pomeranian Journal of Life Sciences, 2018-03, Vol.64 (1)

2018

Volltextzugriff (PDF)

PLEJOTROPOWE DZIAŁANIE INHIBITORÓW 3-HYDROKSY‑3-METYLO-GLUTARYLO-KOENZYMU A (STATYN). POTENCJAŁ LECZNICZY W UKŁADOWYCH CHOROBACH TKANKI ŁĄCZNEJ

Pomeranian Journal of Life Sciences, 2016-07, Vol.60 (1)

Kotyla, Przemysław J.

2016

Volltextzugriff (PDF)

Effectiveness of subcutaneously administered methotrexate in patients with rheumatoid arthritis

Advances in clinical and experimental medicine : official organ Wroclaw Medical University, 2019-09, Vol.28 (9), p.1229-1235

2019

Volltextzugriff (PDF)

Tumor necrosis factor-alpha as a potential target in the treatment of systemic lupus erythematosus: a role for the HMG-CoA reductase inhibitor simvastatin

Journal of rheumatology, 2006-11, Vol.33 (11), p.2361

2006

Volltextzugriff (PDF)

Pravastatin, a 3-hydroxy-3-methyl-glutharyl coenzyme A inhibitor does not show pleiotropic effects in patients with systemic lupus erythematosus

Rheumatology international, 2009, Vol.29 (3), p.353-354

Kotyla, Przemyslaw J.

2009

Volltextzugriff (PDF)

1 – 25 von 52

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(49)
Mit Volltextzugriff
(34)

Publikationsform

Artikel
(51)
Webseiten
(1)

Sprache

Englisch
(45)
Polnisch
(7)

Erscheinungsjahr

n.n

Thema

Science & Technology
(32)
Life Sciences & Biomedicine
(31)
Humans
(29)
Rheumatology
(14)
Female
(12)
Middle Aged
(9)
Arthritis, Rheumatoid - Drug Therapy
(8)
Cytokines
(7)
Rheumatoid Arthritis
(7)
Adult
(6)
Autoimmune Diseases
(6)
Disease
(6)
Male
(6)
Animals
(5)
Inflammation
(5)
Physical Sciences
(5)
Proteins
(5)
Review
(5)
Arthritis
(4)
Atherosclerosis
(4)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Immunomodulatory Effects of Diet and Nutrients in Systemic Lupus Erythematosus (SLE): A Systematic Review

Thromboembolic Adverse Drug Reactions in Janus Kinase (JAK) Inhibitors: Does the Inhibitor Specificity Play a Role?

MicroRNA (miRNA): A New Dimension in the Pathogenesis of Antiphospholipid Syndrome (APS)

Differential Impact of Biologic Therapy on Heart Function Biomarkers in Rheumatoid Arthritis Patients: Observational Study on Etanercept, Adalimumab, and Tocilizumab

Hyperferritinaemia: An Iron Sword of Autoimmunity

Editorial: Autoimmunity and cardiovascular diseases

Vitamin D Status in Patients with Primary Antiphospholipid Syndrome (PAPS): A Systematic Review and Meta-Analysis

Clinical Aspects of Janus Kinase (JAK) Inhibitors in the Cardiovascular System in Patients with Rheumatoid Arthritis

Cytometric Characterization of Main Immunocompetent Cells in Patients with Systemic Sclerosis: Relationship with Disease Activity and Type of Immunosuppressive Treatment

Bimodal Function of Anti-TNF Treatment: Shall We Be Concerned about Anti-TNF Treatment in Patients with Rheumatoid Arthritis and Heart Failure?

Prevalence of antiphospholipid antibodies in Behçet's disease: A systematic review and meta-analysis

Short course of simvastatin has no effect on markers of endothelial activation in normolipidemic patients with systemic sclerosis

Are Janus Kinase Inhibitors Superior over Classic Biologic Agents in RA Patients?

Statins Therapy for Connective Tissue Diseases: New Therapeutic Opportunities

Insulin resistance varies across connective tissue diseases patients: comparison between rheumatoid arthritis, systemic lupus erythematosus and systemic sclerosis

Low dose of simvastatin reduces disease activity and improves endothelial function in patients with systemic lupus erythematosus

Serum concentration of surfactant protein D in patients with systemic sclerosis: The potential marker of the interstitial lung disease severity

Infliximab treatment increases left ventricular ejection fraction in patients with rheumatoid arthritis: assessment of heart function by echocardiography, endothelin 1, interleukin 6, and NT-pro brain natriuretic peptide

Atorvastatin Pleiotropic Effects Mediated Via Suppression of TNF-α in Congestive Heart Failure Patients with Initial Normal TNF-α Levels

Fibroblast Growth Factor 23 to Alpha-Klotho Index Correlates with Systemic Sclerosis Activity: A Proposal for Novel Disease Activity Marker

Patogeneza zapaleń naczyń związanych z przeciwciałami przeciwko cytoplazmie neutrofilów

PLEJOTROPOWE DZIAŁANIE INHIBITORÓW 3-HYDROKSY‑3-METYLO-GLUTARYLO-KOENZYMU A (STATYN). POTENCJAŁ LECZNICZY W UKŁADOWYCH CHOROBACH TKANKI ŁĄCZNEJ

Effectiveness of subcutaneously administered methotrexate in patients with rheumatoid arthritis

Tumor necrosis factor-alpha as a potential target in the treatment of systemic lupus erythematosus: a role for the HMG-CoA reductase inhibitor simvastatin

Pravastatin, a 3-hydroxy-3-methyl-glutharyl coenzyme A inhibitor does not show pleiotropic effects in patients with systemic lupus erythematosus

Suchergebnisse filtern